Welcome!
The Georgia Association of Sleep Professionals, established in July 2008, is a statewide association, that strives to enhance the quality of human life by supporting an environment in which sleep medicine professionals can provide the highest quality of care.


 GASP 2016 Meeting
Save the date: GASP 2016 meeting will be held on Saturday, September 24th, in Atlanta, GA

More information coming soon!
 About GASP
The Georgia Association of Sleep Professionals, established in July 2008, is a statewide association, that strives to enhance the quality of human life by supporting an environment in which sleep medicine professionals can provide the highest quality of care.

more...
 GASP News
Message from the GASP President

Dear Georgia Association of Sleep Professionals (GASP) members,
I wanted to share with you a few developments in our professional society:

First, after the election ballots were counted, we have a new Board of Directors (BOD) – see the other announcement that we posted a week ago with the new positions filled. Let me extend my welcome to the new GASP BOD members and I am looking forward to start working with them.

Second, the GASP 2015 Annual Meeting webcast is now available for viewing. The attendees of the live meeting earned 8 CE hours (AMA PRA, CEC and/or CRCEs) and now 3 additional AMA PRA Credits are available for viewing (in both Clinical and Technical tracks).

Last and not least, we have a new management agreement for GASP. We were able to sign a new management contract that gives us staff support from American Academy of Sleep Medicine (AASM). Let's all thank Tara Morrison and Maryann McGrail from The Association Company for their services over the years, for transferring the society's documents to the new management staff and let’s assure them that we are looking forward at possible new models of collaboration in the future. Our new contact person and support staff (from AASM) is Ted Thurn (TThurn@aasmnet.org), while our website manager remains Tim Barnash (tbarnash@ufl.edu). With our renewed and strengthened ties with the AASM, I am hoping that we will also be able to reach the goal of increasing our membership, especially among physicians, psychologists, dentists and other professionals in the field of sleep medicine. Let’s all agree to make an effort to recruit at least 3 new members each in our organization. This way, our society will be renewed and will become stronger for any new legislative, regulatory or professional challenges that may come our way!

Regards,
Octavian Ioachimescu, MD, PhD
GASP President


Message from GASP President about GASP Board of Directors (BOD) Election Results:

Dear GASP Members,
I'm pleased to inform you of the results of the GASP BOD Election:

President Elect
Amy Blanchard, MD

Secretary
Kim Goins, RSPGT

Clinical Board Member
James Daly, III, MD

Technical Board Member
David Gregory, RPSGT, RST

Facility Board Member
Roberta Leu, MD

The above will join the current BOD members:

President
Octavian Ioachimescu, MD, PhD

Treasurer
Jarrod Rowe, RPSGT

Immediate Past President
Hitendra Patel, MD

Clinical Board Member
Mayoor Patel, DDS, MS

Technical Board Member
Kelly Gladden, RRT, RPSGT, RST

Facility Board Member
Parina Shah, MD

Please join me in congratulating the new members of the Board!

Additionally, many thanks to Demi Collins BS, BA, RPSGT, RST, Nancy Collop, MD, Heidi Riney, MD and Scott Leibowitz, MD for their service to the GASP BOD for the past 2 years. I also want to thank Hitendra Patel, MD, Immediate Past President for his contributions and leadership.

Yours sincerely,
Octavian C. Ioachimescu
GASP President




Field Safety Notice about ASV therapy:

ResMed Corporation posted in May an announcement regarding preliminary results of the SERVE-HF Study, comparing adaptive servo-ventilation (ASV) to usual care in patients with heart failure with reduced ejection fraction (LVEF < 45%) and predominantly central sleep apnea (AHI > 15, with > 50% central events). As noted in their initial announcement, treatment with ASV was associated with a significant increase in mortality, from 7.5% per year in the usual care group to 10% per year in the ASV group. Although analysis of the data is quite preliminary, it appears that the lower the LV ejection fraction, the greater the excess mortality risk in the ASV-treated group. No other predictors of risk or safety have yet been identified. Central sleep apnea was well controlled in a large majority of patients, and the pressures required for control were generally low (most patients had an EPAP of 5 cm H2O); neither failure to control sleep apnea with ASV, nor the pressures required for control of sleep apnea, appear to identify an at-risk subgroup. No significant improvements in quality of life were seen with ASV.

At this time, ResMed recommends that patients with symptomatic heart failure, predominantly central sleep apnea, and LVEF < 45% not to be started on ASV. They recommend that patients with these characteristics already on ASV be evaluated and a risk-benefit determination be made on an individual basis regarding withdrawal of therapy, taking into consideration symptomatic benefits versus increased mortality risk.

More...
 GASP Resources

SLEEP
JOBS



SLEEP ACTIVITIES
CALENDAR